Iridex (IRIX) Long-Term Deferred Tax (2011 - 2022)
Iridex (IRIX) recorded quarterly Long-Term Deferred Tax of $80000.0 in Q4 2022, up 220.0% quarter-over-quarter from $25000.0 in Q1 2022, and up 220.0% on a YoY basis from $25000.0 in Q4 2021.
Iridex (IRIX) Long-Term Deferred Tax (2011 - 2022) Analysis & Trends
Iridex's Long-Term Deferred Tax history runs 6 years deep, the most recent figure standing at $80000.0 for Q4 2022.
- In Q4 2022, Long-Term Deferred Tax rose 220.0% year-over-year to $80000.0; the TTM figure through Dec 2022 stood at $80000.0 (up 220.0% YoY), while the FY2022 annual figure was $80000.0, up 220.0% from the prior year.
- Long-Term Deferred Tax was $80000.0 for Q4 2022 at Iridex, up from $25000.0 in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $80000.0 in Q4 2022 to a low of $25000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Iridex | 19.91 Mn | 15.31 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 80,000.00 |
| Jan 1, 2022 | 25,000.00 |
| Oct 1, 2016 | 8.99 Mn |
| Jul 2, 2016 | 8.99 Mn |
| Apr 2, 2016 | 8.99 Mn |
| Jan 2, 2016 | 8.99 Mn |
| Oct 3, 2015 | 7.15 Mn |
| Jul 4, 2015 | 7.15 Mn |
| Apr 4, 2015 | 7.00 Mn |
| Jan 3, 2015 | 7.15 Mn |
| Dec 28, 2013 | 10.00 Mn |
| Dec 29, 2012 | 10.10 Mn |
| Dec 31, 2011 | 11.70 Mn |